InsidersTradesSigma
Total declarations
Companies
▲ Purchases (1 ops.)
▼ Sales (0 ops.)
Insider track record
Board DirectorDisclosed buys
1
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Explore the full record of transactions filed by Russell Angus C., Director. Insider active across 3 companies, notably Revance Therapeutics, Inc.. In total, 9 filings have been logged. Breakdown: 1 buy · 0 sell. Total volume traded: €89k. Activity tracked since 5 May 2021. The latest transaction was disclosed on 4 February 2025 (U). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to Russell Angus C.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations9 total
36,506 shares@ US$3.6542.0% of flowCommon StockSEC:0000950170-25-015322:0
15,000 shares0Common StockSEC:0001479290-24-000089:0
3,534 shares0Common StockSEC:0001479290-23-000060:0
1,984 sharesCommon StockSEC:0001209191-22-046966:0
6,059 shares0Common StockSEC:0001479290-22-000059:0
6,400 shares@ US$15.740840.8% of flowCommon StockSEC:0001479290-21-000173:0
Canonical exit: 13 Mar 2022 (T+90)
96,864 sharesCommon StockSEC:0001387131-21-008440:0
24,720 shares@ US$2.20100.0% of flowCommon Shares, no par valueSEC:0001493152-21-015786:0
4,013 shares0Common StockSEC:0001479290-21-000114:0
9 of 9 declarations
About Russell Angus C.
Angus C. Russell serves as a Board Member at Revance Therapeutics, Inc., Lineage Cell Therapeutics, Inc., and TherapeuticsMD, Inc. He plays a key role in the governance of these companies, bringing his expertise in strategy and sustainability. His commitment to innovation and operational efficiency is essential for the success of the boards.
